Keros Therapeutics Reports Recent First Quarter 2025 Financial Results

Go back to Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
(NASDAQ: KROS) Delayed: 11.17 -0.14 (1.24%)
Previous Close $11.31    52 Week High
Open $11.16    52 Week Low
Day High $11.20    P/E N/A 
Day Low $11.00    EPS
Volume 128,792